Ireland Peripheral Arterial Disease Market (2025-2031) | Forecast, Value, Analysis, Segmentation, Growth, Industry, Companies, Size & Revenue, Trends, Outlook, Share, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Ireland Country Macro Economic Indicators

3.2 Ireland Peripheral Arterial Disease Market Revenues & Volume, 2021 & 2031F

3.3 Ireland Peripheral Arterial Disease Market - Industry Life Cycle

3.4 Ireland Peripheral Arterial Disease Market - Porter's Five Forces

3.5 Ireland Peripheral Arterial Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F

3.6 Ireland Peripheral Arterial Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.7 Ireland Peripheral Arterial Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F

3.8 Ireland Peripheral Arterial Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of lifestyle diseases such as diabetes and obesity leading to a higher incidence of peripheral arterial disease in Ireland.

4.2.2 Growing aging population in Ireland, which is more prone to peripheral arterial disease, driving the demand for treatment and management.

4.2.3 Technological advancements in minimally invasive procedures and devices for the treatment of peripheral arterial disease, improving patient outcomes and expanding the market.

4.3 Market Restraints

4.3.1 High treatment costs associated with peripheral arterial disease management, limiting access to care for some patients.

4.3.2 Lack of awareness about peripheral arterial disease among the general population, leading to underdiagnosis and undertreatment.

4.3.3 Stringent regulatory requirements and approval processes for new treatment options, delaying market entry and innovation.

6.1 Ireland Peripheral Arterial Disease Market, By Treatment Type

6.1.1 Overview and Analysis

6.1.2 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Treatment Type, 2021- 2031F

6.1.3 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Devices, 2021- 2031F

6.1.4 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Catheters, 2021- 2031F

6.1.5 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Drugs, 2021- 2031F

6.1.6 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F

6.2 Ireland Peripheral Arterial Disease Market, By Route of Administration

6.2.1 Overview and Analysis

6.2.2 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.2.3 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Parenteral, 2021- 2031F

6.2.4 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F

6.3 Ireland Peripheral Arterial Disease Market, By End Users

6.3.1 Overview and Analysis

6.3.2 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.3.4 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 Ireland Peripheral Arterial Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.4.4 Ireland Peripheral Arterial Disease Market Revenues & Volume, By Others, 2021- 2031F

7.1 Ireland Peripheral Arterial Disease Market Export to Major Countries

7.2 Ireland Peripheral Arterial Disease Market Imports from Major Countries

8.1 Average length of hospital stay for peripheral arterial disease patients undergoing treatment.

8.2 Number of peripheral arterial disease screenings conducted annually in Ireland.

8.3 Adoption rate of minimally invasive procedures for peripheral arterial disease treatment.

8.4 Patient satisfaction scores with peripheral arterial disease management services.

8.5 Rate of complications or rehospitalizations post-peripheral arterial disease treatment.

9.1 Ireland Peripheral Arterial Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F

9.2 Ireland Peripheral Arterial Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.3 Ireland Peripheral Arterial Disease Market Opportunity Assessment, By End Users, 2021 & 2031F

9.4 Ireland Peripheral Arterial Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Ireland Peripheral Arterial Disease Market Revenue Share, By Companies, 2024

10.2 Ireland Peripheral Arterial Disease Market Competitive Benchmarking, By Operating and Technical Parameters